| scholarly article | Q13442814 |
| P2093 | author name string | Polack A | |
| Hörtnagel K | |||
| Feederle R | |||
| Klobeck G | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| Transcription enhancer identified near the human C mu immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphoma. | Q48394103 | ||
| The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region | Q49162171 | ||
| A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus | Q56838225 | ||
| A nuclear DNA attachment element mediates elevated and position-independent gene activity | Q59073618 | ||
| A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells | Q59074575 | ||
| A variant translocation places the λ immunoglobulin genes 3′ to the c-myc oncogene in Burkitt's lymphoma | Q59093573 | ||
| A physical map and analysis of the murine C kappa-RS region show the presence of a conserved element | Q68342289 | ||
| Role of chromosome translocations in human neoplasia | Q68818574 | ||
| Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma | Q69457818 | ||
| Normal expression of a rearranged and mutated c-myc oncogene after transfection into fibroblasts | Q69552626 | ||
| Transgenic mice | Q70082646 | ||
| The mechanism of inactivation of the normal c-myc gene locus in human Burkitt lymphoma cells | Q70390232 | ||
| A positive role for histone acetylation in transcription factor access to nucleosomal DNA | Q70535287 | ||
| Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8) and t(8;22) translocations | Q70866890 | ||
| Multiple nuclear factors interact with the immunoglobulin enhancer sequences | Q24296245 | ||
| Chromosome 8 breakpoint far 3' of the c-myc oncogene in a Burkitt's lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus | Q24531855 | ||
| Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc | Q30791622 | ||
| Two antisense promoters in the immunoglobulin mu-switch region drive expression of c-myc in the Burkitt's lymphoma cell line BL67. | Q33224591 | ||
| Chromosome translocations clustered 5' of the murine c-myc gene qualitatively affect promoter usage: implications for the site of normal c-myc regulation | Q33931387 | ||
| Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives | Q33932184 | ||
| Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites | Q34161702 | ||
| Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs | Q34253051 | ||
| N segment insertion and region-directed somatic hypermutation in a kappa gene of a t(2;8) chromosomal translocation | Q34686804 | ||
| Complementation between two cell lines lacking kappa enhancer activity: implications for the developmental control of immunoglobulin transcription | Q36000787 | ||
| Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors | Q36684975 | ||
| Sequences in the human c-myc P2 promoter affect the elongation and premature termination of transcripts initiated from the upstream P1 promoter | Q36703451 | ||
| Characterization of the human immunoglobulin kappa gene 3' enhancer: functional importance of three motifs that demonstrate B-cell-specific in vivo footprints | Q36705439 | ||
| Three breakpoints of variant t(2;8) translocations in Burkitt's lymphoma cells fall within a region 140 kilobases distal from c-myc | Q36777587 | ||
| Serum-inducible expression of transfected human c-myc genes | Q36795479 | ||
| PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity | Q36809426 | ||
| A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus | Q36885800 | ||
| Electric field-mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells | Q36910136 | ||
| Fine Mapping of an Immunoglobulin Gene Activator | Q36945043 | ||
| Activation of a translocated c-myc gene: role of structural alterations in the upstream region | Q37576047 | ||
| Premature termination of transcription from the P1 promoter of the mouse c-myc gene | Q37648162 | ||
| Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene | Q40062679 | ||
| Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression | Q40419300 | ||
| n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells | Q40497185 | ||
| Generation of a variant t(2;8) translocation of Burkitt's lymphoma by site-specific recombination via the kappa light-chain joining signals | Q40659481 | ||
| The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region | Q40818245 | ||
| Expression of normal and translocated c-myc alleles in Burkitt's lymphoma cells: evidence for different regulation | Q40818267 | ||
| A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE | Q41210330 | ||
| Negative autoregulation of c-myc gene expression is inactivated in transformed cells | Q41233339 | ||
| A human chromosome 8 region with abnormalities in B cell, HTLV-I+ T cell and c-myc amplified tumours | Q41344456 | ||
| Truncation does not abrogate transcriptional downregulation of the c-myc gene by sodium butyrate in Burkitt's lymphoma cells | Q41349782 | ||
| Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo | Q41535694 | ||
| Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift. | Q41548686 | ||
| Scaffold-attached regions (SAR elements) mediate transcriptional effects due to butyrate | Q41633978 | ||
| The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift | Q41657361 | ||
| The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles | Q41750000 | ||
| Immunoglobulin kappa gene expression after stable integration. I. Role of the intronic MAR and enhancer in plasmacytoma cells | Q41758304 | ||
| Immunoglobulin kappa gene enhancers synergistically activate gene expression but independently determine chromatin structure | Q42456490 | ||
| The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription | Q43814141 | ||
| Immunoglobulin gene transcription is activated by downstream sequence elements | Q43904180 | ||
| The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation | Q45019101 | ||
| A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma | Q48390201 | ||
| Activation and somatic mutation of the translocated c-myc gene in burkitt lymphoma cells | Q48393003 | ||
| A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene | Q48393280 | ||
| Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus | Q48393487 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Burkitt lymphoma | Q1016605 |
| P304 | page(s) | 3913-3920 | |
| P577 | publication date | 1993-10-01 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells | |
| P478 | volume | 12 |
| Q33613910 | Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU. |
| Q77340293 | Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma |
| Q36732304 | Evidence for long-range oncogene activation by hepadnavirus insertion |
| Q37342819 | In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development |
| Q34551859 | Involvement of Rad18 in somatic hypermutation |
| Q92669992 | JNK/AP1 Pathway Regulates MYC Expression and BCR Signaling through Ig Enhancers in Burkitt Lymphoma Cells |
| Q34747399 | Molecular cloning, structural organization, sequence, chromosomal assignment, and expression of the mouse alpha-N-acetylgalactosaminidase gene. |
| Q38301775 | NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma |
| Q38436671 | Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2. |
| Q36527994 | Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype |
| Q40022897 | Nucleosomal structures of c-myc promoters with transcriptionally engaged RNA polymerase II. |
| Q30855713 | Regulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elements |
| Q77301724 | Sodium butyrate suppresses apoptosis in human Burkitt lymphomas and murine plasmacytomas bearing c-myc translocations |
| Q41244135 | TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers. |
| Q39221506 | The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects |
| Q37013896 | The c-myc promoter: still MysterY and challenge |
| Q41251712 | The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. |
| Q34405431 | Translocations involving c-myc and c-myc function |
| Q40395601 | Variable pause positions of RNA polymerase II lie proximal to the c-myc promoter irrespective of transcriptional activity. |
| Q39780657 | c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma |
| Q37340989 | c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1. |
Search more.